1. Home
  2. KRMD vs HBIO Comparison

KRMD vs HBIO Comparison

Compare KRMD & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$4.31

Market Cap

195.7M

Sector

Health Care

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.16

Market Cap

25.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
HBIO
Founded
1980
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
195.7M
25.7M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
KRMD
HBIO
Price
$4.31
$5.16
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$6.50
$18.00
AVG Volume (30 Days)
129.7K
199.3K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
$116,176,000.00
Revenue This Year
$20.32
$5.36
Revenue Next Year
$17.38
$7.94
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$1.87
$0.28
52 Week High
$6.61
$5.75

Technical Indicators

Market Signals
Indicator
KRMD
HBIO
Relative Strength Index (RSI) 42.44 77.04
Support Level $4.31 $0.46
Resistance Level $4.34 $5.75
Average True Range (ATR) 0.18 0.39
MACD 0.02 -0.00
Stochastic Oscillator 57.89 57.69

Price Performance

Historical Comparison
KRMD
HBIO

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: